IBDEI1ST ; ; 04-FEB-2020
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,28718,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,28718,1,3,0)
;;=3^Illness Anxiety D/O
;;^UTILITY(U,$J,358.3,28718,1,4,0)
;;=4^F45.21
;;^UTILITY(U,$J,358.3,28718,2)
;;=^5003587
;;^UTILITY(U,$J,358.3,28719,0)
;;=F68.A^^115^1415^6
;;^UTILITY(U,$J,358.3,28719,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,28719,1,3,0)
;;=3^Factitious D/O Imposed on Another
;;^UTILITY(U,$J,358.3,28719,1,4,0)
;;=4^F68.A
;;^UTILITY(U,$J,358.3,28719,2)
;;=^5157309
;;^UTILITY(U,$J,358.3,28720,0)
;;=L98.1^^115^1415^5
;;^UTILITY(U,$J,358.3,28720,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,28720,1,3,0)
;;=3^Factitial Dermatitis
;;^UTILITY(U,$J,358.3,28720,1,4,0)
;;=4^L98.1
;;^UTILITY(U,$J,358.3,28720,2)
;;=^186781
;;^UTILITY(U,$J,358.3,28721,0)
;;=N94.3^^115^1415^9
;;^UTILITY(U,$J,358.3,28721,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,28721,1,3,0)
;;=3^Premenstrual Tension Syndrome
;;^UTILITY(U,$J,358.3,28721,1,4,0)
;;=4^N94.3
;;^UTILITY(U,$J,358.3,28721,2)
;;=^5015919
;;^UTILITY(U,$J,358.3,28722,0)
;;=F91.2^^115^1416^1
;;^UTILITY(U,$J,358.3,28722,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,28722,1,3,0)
;;=3^Conduct D/O,Adolescent-Onset Type
;;^UTILITY(U,$J,358.3,28722,1,4,0)
;;=4^F91.2
;;^UTILITY(U,$J,358.3,28722,2)
;;=^5003699
;;^UTILITY(U,$J,358.3,28723,0)
;;=F91.1^^115^1416^2
;;^UTILITY(U,$J,358.3,28723,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,28723,1,3,0)
;;=3^Conduct D/O,Childhood-Onset Type
;;^UTILITY(U,$J,358.3,28723,1,4,0)
;;=4^F91.1
;;^UTILITY(U,$J,358.3,28723,2)
;;=^5003698
;;^UTILITY(U,$J,358.3,28724,0)
;;=F91.9^^115^1416^3
;;^UTILITY(U,$J,358.3,28724,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,28724,1,3,0)
;;=3^Conduct D/O,Unspec
;;^UTILITY(U,$J,358.3,28724,1,4,0)
;;=4^F91.9
;;^UTILITY(U,$J,358.3,28724,2)
;;=^5003701
;;^UTILITY(U,$J,358.3,28725,0)
;;=F63.81^^115^1416^6
;;^UTILITY(U,$J,358.3,28725,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,28725,1,3,0)
;;=3^Intermittent Explosive D/O
;;^UTILITY(U,$J,358.3,28725,1,4,0)
;;=4^F63.81
;;^UTILITY(U,$J,358.3,28725,2)
;;=^5003644
;;^UTILITY(U,$J,358.3,28726,0)
;;=F63.2^^115^1416^7
;;^UTILITY(U,$J,358.3,28726,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,28726,1,3,0)
;;=3^Kleptomania
;;^UTILITY(U,$J,358.3,28726,1,4,0)
;;=4^F63.2
;;^UTILITY(U,$J,358.3,28726,2)
;;=^5003642
;;^UTILITY(U,$J,358.3,28727,0)
;;=F91.3^^115^1416^8
;;^UTILITY(U,$J,358.3,28727,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,28727,1,3,0)
;;=3^Oppositional Defiant D/O
;;^UTILITY(U,$J,358.3,28727,1,4,0)
;;=4^F91.3
;;^UTILITY(U,$J,358.3,28727,2)
;;=^331955
;;^UTILITY(U,$J,358.3,28728,0)
;;=F63.1^^115^1416^9
;;^UTILITY(U,$J,358.3,28728,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,28728,1,3,0)
;;=3^Pyromania
;;^UTILITY(U,$J,358.3,28728,1,4,0)
;;=4^F63.1
;;^UTILITY(U,$J,358.3,28728,2)
;;=^5003641
;;^UTILITY(U,$J,358.3,28729,0)
;;=F91.8^^115^1416^4
;;^UTILITY(U,$J,358.3,28729,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,28729,1,3,0)
;;=3^Disruptive,Impulse-Control & Conduct D/O,Oth
;;^UTILITY(U,$J,358.3,28729,1,4,0)
;;=4^F91.8
;;^UTILITY(U,$J,358.3,28729,2)
;;=^5003700
;;^UTILITY(U,$J,358.3,28730,0)
;;=R45.6^^115^1416^10
;;^UTILITY(U,$J,358.3,28730,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,28730,1,3,0)
;;=3^Violent Behavior
;;^UTILITY(U,$J,358.3,28730,1,4,0)
;;=4^R45.6
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1ST 3746 printed Sep 23, 2025@19:51:07 Page 2
IBDEI1ST ; ; 04-FEB-2020
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,28718,1,0)
+2 ;;=^358.31IA^4^2
+3 ;;^UTILITY(U,$J,358.3,28718,1,3,0)
+4 ;;=3^Illness Anxiety D/O
+5 ;;^UTILITY(U,$J,358.3,28718,1,4,0)
+6 ;;=4^F45.21
+7 ;;^UTILITY(U,$J,358.3,28718,2)
+8 ;;=^5003587
+9 ;;^UTILITY(U,$J,358.3,28719,0)
+10 ;;=F68.A^^115^1415^6
+11 ;;^UTILITY(U,$J,358.3,28719,1,0)
+12 ;;=^358.31IA^4^2
+13 ;;^UTILITY(U,$J,358.3,28719,1,3,0)
+14 ;;=3^Factitious D/O Imposed on Another
+15 ;;^UTILITY(U,$J,358.3,28719,1,4,0)
+16 ;;=4^F68.A
+17 ;;^UTILITY(U,$J,358.3,28719,2)
+18 ;;=^5157309
+19 ;;^UTILITY(U,$J,358.3,28720,0)
+20 ;;=L98.1^^115^1415^5
+21 ;;^UTILITY(U,$J,358.3,28720,1,0)
+22 ;;=^358.31IA^4^2
+23 ;;^UTILITY(U,$J,358.3,28720,1,3,0)
+24 ;;=3^Factitial Dermatitis
+25 ;;^UTILITY(U,$J,358.3,28720,1,4,0)
+26 ;;=4^L98.1
+27 ;;^UTILITY(U,$J,358.3,28720,2)
+28 ;;=^186781
+29 ;;^UTILITY(U,$J,358.3,28721,0)
+30 ;;=N94.3^^115^1415^9
+31 ;;^UTILITY(U,$J,358.3,28721,1,0)
+32 ;;=^358.31IA^4^2
+33 ;;^UTILITY(U,$J,358.3,28721,1,3,0)
+34 ;;=3^Premenstrual Tension Syndrome
+35 ;;^UTILITY(U,$J,358.3,28721,1,4,0)
+36 ;;=4^N94.3
+37 ;;^UTILITY(U,$J,358.3,28721,2)
+38 ;;=^5015919
+39 ;;^UTILITY(U,$J,358.3,28722,0)
+40 ;;=F91.2^^115^1416^1
+41 ;;^UTILITY(U,$J,358.3,28722,1,0)
+42 ;;=^358.31IA^4^2
+43 ;;^UTILITY(U,$J,358.3,28722,1,3,0)
+44 ;;=3^Conduct D/O,Adolescent-Onset Type
+45 ;;^UTILITY(U,$J,358.3,28722,1,4,0)
+46 ;;=4^F91.2
+47 ;;^UTILITY(U,$J,358.3,28722,2)
+48 ;;=^5003699
+49 ;;^UTILITY(U,$J,358.3,28723,0)
+50 ;;=F91.1^^115^1416^2
+51 ;;^UTILITY(U,$J,358.3,28723,1,0)
+52 ;;=^358.31IA^4^2
+53 ;;^UTILITY(U,$J,358.3,28723,1,3,0)
+54 ;;=3^Conduct D/O,Childhood-Onset Type
+55 ;;^UTILITY(U,$J,358.3,28723,1,4,0)
+56 ;;=4^F91.1
+57 ;;^UTILITY(U,$J,358.3,28723,2)
+58 ;;=^5003698
+59 ;;^UTILITY(U,$J,358.3,28724,0)
+60 ;;=F91.9^^115^1416^3
+61 ;;^UTILITY(U,$J,358.3,28724,1,0)
+62 ;;=^358.31IA^4^2
+63 ;;^UTILITY(U,$J,358.3,28724,1,3,0)
+64 ;;=3^Conduct D/O,Unspec
+65 ;;^UTILITY(U,$J,358.3,28724,1,4,0)
+66 ;;=4^F91.9
+67 ;;^UTILITY(U,$J,358.3,28724,2)
+68 ;;=^5003701
+69 ;;^UTILITY(U,$J,358.3,28725,0)
+70 ;;=F63.81^^115^1416^6
+71 ;;^UTILITY(U,$J,358.3,28725,1,0)
+72 ;;=^358.31IA^4^2
+73 ;;^UTILITY(U,$J,358.3,28725,1,3,0)
+74 ;;=3^Intermittent Explosive D/O
+75 ;;^UTILITY(U,$J,358.3,28725,1,4,0)
+76 ;;=4^F63.81
+77 ;;^UTILITY(U,$J,358.3,28725,2)
+78 ;;=^5003644
+79 ;;^UTILITY(U,$J,358.3,28726,0)
+80 ;;=F63.2^^115^1416^7
+81 ;;^UTILITY(U,$J,358.3,28726,1,0)
+82 ;;=^358.31IA^4^2
+83 ;;^UTILITY(U,$J,358.3,28726,1,3,0)
+84 ;;=3^Kleptomania
+85 ;;^UTILITY(U,$J,358.3,28726,1,4,0)
+86 ;;=4^F63.2
+87 ;;^UTILITY(U,$J,358.3,28726,2)
+88 ;;=^5003642
+89 ;;^UTILITY(U,$J,358.3,28727,0)
+90 ;;=F91.3^^115^1416^8
+91 ;;^UTILITY(U,$J,358.3,28727,1,0)
+92 ;;=^358.31IA^4^2
+93 ;;^UTILITY(U,$J,358.3,28727,1,3,0)
+94 ;;=3^Oppositional Defiant D/O
+95 ;;^UTILITY(U,$J,358.3,28727,1,4,0)
+96 ;;=4^F91.3
+97 ;;^UTILITY(U,$J,358.3,28727,2)
+98 ;;=^331955
+99 ;;^UTILITY(U,$J,358.3,28728,0)
+100 ;;=F63.1^^115^1416^9
+101 ;;^UTILITY(U,$J,358.3,28728,1,0)
+102 ;;=^358.31IA^4^2
+103 ;;^UTILITY(U,$J,358.3,28728,1,3,0)
+104 ;;=3^Pyromania
+105 ;;^UTILITY(U,$J,358.3,28728,1,4,0)
+106 ;;=4^F63.1
+107 ;;^UTILITY(U,$J,358.3,28728,2)
+108 ;;=^5003641
+109 ;;^UTILITY(U,$J,358.3,28729,0)
+110 ;;=F91.8^^115^1416^4
+111 ;;^UTILITY(U,$J,358.3,28729,1,0)
+112 ;;=^358.31IA^4^2
+113 ;;^UTILITY(U,$J,358.3,28729,1,3,0)
+114 ;;=3^Disruptive,Impulse-Control & Conduct D/O,Oth
+115 ;;^UTILITY(U,$J,358.3,28729,1,4,0)
+116 ;;=4^F91.8
+117 ;;^UTILITY(U,$J,358.3,28729,2)
+118 ;;=^5003700
+119 ;;^UTILITY(U,$J,358.3,28730,0)
+120 ;;=R45.6^^115^1416^10
+121 ;;^UTILITY(U,$J,358.3,28730,1,0)
+122 ;;=^358.31IA^4^2
+123 ;;^UTILITY(U,$J,358.3,28730,1,3,0)
+124 ;;=3^Violent Behavior
+125 ;;^UTILITY(U,$J,358.3,28730,1,4,0)
+126 ;;=4^R45.6
